Home/Filings/4/0001415889-24-006282
4//SEC Filing

Terrillion Scott 4

Accession 0001415889-24-006282

CIK 0001346830other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:24 PM ET

Size

5.1 KB

Accession

0001415889-24-006282

Insider Transaction Report

Form 4
Period: 2024-02-29
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Transactions
  • Sale

    Common Stock

    2024-02-29$0.89/sh3,293$2,93191,000 total
Footnotes (1)
  • [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on September 7, 2018 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1
  • filerCIK 0001706426

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:24 PM ET
Size
5.1 KB